Similarly, while MALAT1 has been extensively studied as an oncogenic lncRNA, a recent study suggests that downregulation of MALAT1 results in increased cancer cell migration and correlates with reduced patient survival [106]. This evidence concerns the gene MALAT1 and cancer.